Bevacizumab (Bev)-based therapy for patients (pts) with colorectal cancer (CRC): McGill University and Segal Cancer Centre experience. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wasserman, David
  • Bouganim, N
  • Batist, G
  • Metrakos, P
  • Chaudhury, P
  • Hassanain, M
  • Kavan, P

publication date

  • May 20, 2011